Mark R. Barakat, MD

Articles by Mark R. Barakat, MD

Image credit: ©ipuwadol – stock.adobe.com

Precision medicine in diabetic macular edema: Expert consensus on the efficacy and safety of the 0.19-mg fluocinolone acetonide implant

September 22nd 2023

Results from expert surveys provide snapshots of our understanding of DME and shed light on where the 0.19-mg FAc implant stands in the current standard of care.

Latest Updated Articles

Precision medicine in diabetic macular edema: Expert consensus on the efficacy and safety of the 0.19-mg fluocinolone acetonide implant
September 22nd 2023

Mark R. Barakat, MD

Articles by Mark R. Barakat, MD

Precision medicine in diabetic macular edema: Expert consensus on the efficacy and safety of the 0.19-mg fluocinolone acetonide implant

Latest Updated Articles

Trending on Modern Retina

Merck launches phase 2b/3 MALBEC trial of MK-8748 in wet AMD

FDA grants RMAT designation to RTx-015 optogenetic gene therapy for retinitis pigmentosa

FDA approves extended dosing intervals up to 20 weeks for EYLEA HD in wAMD and DME

OLN324 shows comparable vision gains, potential durability advantage vs faricimab in phase 1b wAMD, DME study

Getting to the root of geographic atrophy: Diagnosis and management